[1]
N. Shehzadi, “Hypoglycemic, hepatoprotective and molecular docking studies of 5-[(4-chlorophenoxy) methyl]-1, 3, 4-oxadiazole-2-thiol”, Bangladesh J Pharmacol, vol. 13, no. 2, pp. 149–156, May 2018.